Cumberland Pharmaceuticals (CPIX) Capital Expenditures (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Capital Expenditures of -$1.0 for Q4 2025, down 100.0% sequentially from $23788.0 in Q3 2025, and down 100.04% YoY from $2283.0 in Q4 2024.
Cumberland Pharmaceuticals (CPIX) Capital Expenditures (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Capital Expenditures for 16 years, with the latest figure at -$1.0 in Q4 2025.
- Quarterly Capital Expenditures fell 100.04% year-over-year to -$1.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $50273.0 (down 30.63% YoY) and the FY2025 annual result came in at $97903.0, up 47.31% from the prior year.
- Capital Expenditures slipped to -$1.0 in Q4 2025 per CPIX's latest filing, from $23788.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $137255.0 in Q2 2022 and troughed at -$153528.0 in Q4 2022.
- A 5-year average of $32565.6 and a median of $26736.0 in 2022 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 810.6% in 2022, down 1797.0% in 2022.
- Over 5 years, Capital Expenditures stood at $9047.0 in 2021, then tumbled by 1797.0% to -$153528.0 in 2022, then surged by 131.7% to $48673.0 in 2023, then tumbled by 95.31% to $2283.0 in 2024, then tumbled by 100.04% to -$1.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$1.0, $23788.0, and $26486.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | 38,283.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38,283.00 |
| Jun 30, 2026 | 38,283.00 |
| Dec 31, 2025 | -1.00 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | 23,788.00 |
| Sep 30, 2025 | 23,788.00 |
| Jun 30, 2025 | 26,486.00 |
| Jun 30, 2025 | 26,486.00 |
| Mar 31, 2025 | 47,630.00 |
| Mar 31, 2025 | 47,630.00 |
| Dec 31, 2024 | 2,283.00 |
| Dec 31, 2024 | 2,283.00 |
| Sep 30, 2024 | 15,379.00 |
| Sep 30, 2024 | 15,379.00 |
| Jun 30, 2024 | 7,178.00 |
| Jun 30, 2024 | 7,178.00 |
| Mar 31, 2024 | 41,621.00 |
| Mar 31, 2024 | 41,621.00 |
| Dec 31, 2023 | 48,673.00 |
| Dec 31, 2023 | 48,673.00 |